Page last updated: 2024-08-24

adenosine and hirudin

adenosine has been researched along with hirudin in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (27.27)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	8 (72.73)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Michaeli, D; Orloff, KG	1
Hoak, JC; Wu, KK	1
Haslam, RJ; Rosson, GM	1
Aïssaoui, N; Danchin, N	1
Fan, L; Liu, J; Yang, L; Zhang, C; Zhou, J	1
Basra, SS; Lakkis, NM; Tsai, P	1
Gupta, K; Singh, D; Vacek, JL	1
Baber, U; Badimon, JJ; Crippa, M; Giannarelli, C; Mehran, R; Rodriguez, D; Sartori, S; Tewar, MP; Vorchheimer, DA; Zafar, MU	1
Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L	1
Baber, U; Berger, PB; Currier, J; Dave, RH; Henry, TD; Mehran, R; Nayyar, P; Rafique, AM; Tobis, J; Wang, TY	1
Buszman, P; Cook, S; Fabris, E; Kedhi, E; Kennedy, MW; van der Ent, M; von Birgelen, C; Wedel, H; Zijlstra, F	1

Reviews

5 review(s) available for adenosine and hirudin

Article	Year
Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Disease Management; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine	2010
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. Journal of the American College of Cardiology, 2011, Nov-22, Volume: 58, Issue:22 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine; Uremia	2011
Anticoagulation and antiplatelet therapy in acute coronary syndromes. Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin	2014
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? American heart journal, 2014, Volume: 168, Issue:5 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin	2014
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. JACC. Cardiovascular interventions, 2016, 05-23, Volume: 9, Issue:10 Topics: Adenosine; Antithrombins; Bayes Theorem; Blood Platelets; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Evidence-Based Medicine; Hirudins; Humans; Markov Chains; Monte Carlo Method; Network Meta-Analysis; Odds Ratio; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Recombinant Proteins; Risk Factors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Treatment Outcome	2016

Trials

2 trial(s) available for adenosine and hirudin

Article	Year
Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin. Thrombosis and haemostasis, 2014, Volume: 112, Issue:5 Topics: Adenosine; Adult; Antithrombins; Aspirin; Blood Coagulation; Clopidogrel; Cross-Over Studies; Drug Synergism; Female; Healthy Volunteers; Hirudins; Humans; Male; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Recombinant Proteins; Thrombelastography; Ticagrelor; Ticlopidine	2014
A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial". American heart journal, 2017, Volume: 188 Topics: Adenosine; Antithrombins; Cause of Death; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Europe; Follow-Up Studies; Hirudins; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Period; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Recombinant Proteins; ST Elevation Myocardial Infarction; Survival Rate; Ticagrelor; Time Factors; Treatment Outcome	2017

Article

Year

Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin.

Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

Topics: Adenosine; Adult; Antithrombins; Aspirin; Blood Coagulation; Clopidogrel; Cross-Over Studies; Drug Synergism; Female; Healthy Volunteers; Hirudins; Humans; Male; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Recombinant Proteins; Thrombelastography; Ticagrelor; Ticlopidine

2014

A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".

American heart journal, 2017, Volume: 188

Topics: Adenosine; Antithrombins; Cause of Death; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Europe; Follow-Up Studies; Hirudins; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Period; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Recombinant Proteins; ST Elevation Myocardial Infarction; Survival Rate; Ticagrelor; Time Factors; Treatment Outcome

2017

Other Studies

4 other study(ies) available for adenosine and hirudin

Article	Year
Fibrin-induced release of platelet serotonin. The American journal of physiology, 1976, Volume: 231, Issue:2 Topics: Adenosine; Adenosine Diphosphate; Blood Platelets; Calcium; Fibrin; Fibrinogen; Hirudins; Humans; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins E; Serotonin; Thrombin	1976
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thrombosis and haemostasis, 1976, Jun-30, Volume: 35, Issue:3 Topics: Adenosine; Adult; Aged; Angina Pectoris; Apyrase; Arterial Occlusive Diseases; Aspirin; Coronary Disease; Dipyridamole; Heparin; Hirudins; Humans; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Platelet Aggregation; Prostaglandins E	1976
Aggregation of human blood platelets by vasopressin. The American journal of physiology, 1972, Volume: 223, Issue:4 Topics: Acetates; Adenosine; Animals; Anticoagulants; Blood Platelets; Caffeine; Carbon Isotopes; Cations, Divalent; Cell Aggregation; Chelating Agents; Citrates; Creatine Kinase; Cyclic AMP; Dogs; Ethylmaleimide; Fibrinogen; Glycols; Hirudins; Humans; Imipramine; Phosphocreatine; Prostaglandins; Rabbits; Serotonin; Swine; Vasopressins	1972
Loading solution prevents activation damage of human platelets before lyophilization. Cryobiology, 2011, Volume: 63, Issue:3 Topics: Adenosine; Algorithms; Alprostadil; Arginine; Biomarkers; Blood Platelets; Blood Preservation; Cell Size; Cilostazol; Excipients; Freeze Drying; Hirudins; Humans; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Membrane Glycoproteins; Recombinant Proteins; Tetrazoles	2011

chemdatabank.com